Course Provider
Learning Objectives
Upon completion of this activity, participants should be better able to assess the role of molecular, predictive, and prognostic factors in guiding treatment decisions for patients with hematologic malignancies
Upon completion of this activity, participants should be better able to differentiate targeted agents and immunotherapies based on mechanism of action, new safety and efficacy data, and place in therapy
Upon completion of this activity, participants should be better able to apply current evidence and guidelines for the diagnosis, treatment, and management of hematologic malignancies
Upon completion of this activity, participants should be better able to employ interprofessional strategies for care coordination and referral to specialists for patients with hematologic malignancies